seed
Stage
2018
Founded
2
Investors
About
Pencil Biosciences develops a novel synthetic gene modulation platform that offers precise gene editing without causing DNA breaks or nicks, aiming to enable new therapeutic options for patients with rare diseases and cancer.
Explore Pencil Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.